Back | Next |
home / stock / sprb / sprb message board
Subject | By | Source | When |
---|---|---|---|
The gaining | pzottkpz | investorshub | 04/16/2023 7:03:24 PM |
oh yeah news for the day | MiamiGent | investorshub | 04/16/2023 6:22:52 AM |
Time for a bounce? | TheFinalCD | investorshub | 04/16/2023 5:05:38 AM |
$SPRB Looks pretty positive | pzottkpz | investorshub | 04/15/2023 12:10:16 PM |
now that | pzottkpz | investorshub | 02/09/2023 8:05:58 PM |
bahahahaha | pzottkpz | investorshub | 02/09/2023 2:32:06 PM |
took this one | pzottkpz | investorshub | 01/26/2023 5:10:29 PM |
its like a circus act | pzottkpz | investorshub | 01/19/2023 4:03:02 PM |
does the | pzottkpz | investorshub | 01/19/2023 10:44:36 AM |
mama said | pzottkpz | investorshub | 01/18/2023 9:57:48 PM |
cant wait to see | pzottkpz | investorshub | 01/18/2023 1:10:32 PM |
pumpy dumpy | pzottkpz | investorshub | 01/17/2023 6:36:58 PM |
this stock only seems to have | pzottkpz | investorshub | 01/17/2023 6:09:24 PM |
lying pumpers | pzottkpz | investorshub | 01/15/2023 1:45:30 PM |
$SPRB drop was bot. | MiamiGent | investorshub | 01/13/2023 6:38:12 PM |
does anyone know | pzottkpz | investorshub | 01/12/2023 9:09:26 PM |
someone | pzottkpz | investorshub | 01/12/2023 2:41:05 PM |
reminder | pzottkpz | investorshub | 01/12/2023 4:50:10 AM |
$SPRB Closed at 2.90 + .29 or + 11.11% | MiamiGent | investorshub | 01/12/2023 12:51:13 AM |
stock | pzottkpz | investorshub | 01/11/2023 5:16:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Spruce Biosciences Inc. Company Name:
SPRB Stock Symbol:
NASDAQ Market:
Analyses of Data from CAHmelia-203 in Adult Congenital Adrenal Hyperplasia (CAH) Demonstrate Correlation Between Tildacerfont Response and Baseline Glucocorticoid (GC) Dose and Drug Compliance Posters Highlighting Baseline Characteristics from the CAHmelia Program in Adult CAH and CAHptai...
Presentation to highlight baseline characteristics of Spruce’s CAHptain program evaluating tildacerfont in pediatric congenital adrenal hyperplasia (CAH) The company is also highlighting baseline characteristics from its CAHmelia program evaluating tildacerfont in adult CAH in a po...
Presentation to highlight baseline characteristics of Spruce’s CAHmelia program evaluating tildacerfont in adult congenital adrenal hyperplasia (CAH), as an illustration of outcomes of current pediatric CAH disease management Spruce Biosciences, Inc . (Nasdaq: SPRB), a late-s...